Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Psychiatry Research|May 10, 2023
The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 reportManish Dama, Michelle Wu, Vanessa K Tassone, et al.Pharmacopsychiatry|March 2, 2021
Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND ReportEmma Morton, Venkat Bhat, Peter Giacobbe, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 14, 2023
The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 ReportKate L Harkness, Trisha Chakrabarty, Sakina J Rizvi, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of CareRaymond W Lam, Diane McIntosh, JianLi Wang, et al.Brain and Behavior|March 25, 2022
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapyCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.Focus (American Psychiatric Publishing)|February 5, 2020
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine TreatmentsArun V Ravindran, Lynda G Balneaves, Guy Faulkner, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine TreatmentsArun V Ravindran, Lynda G Balneaves, Guy Faulkner, et al.CNS Drugs|April 16, 2021
Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study ReportEmma Morton, Venkat Bhat, Peter Giacobbe, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation TreatmentsRoumen V Milev, Peter Giacobbe, Sidney H Kennedy, et al.Journal of Psychopharmacology (Oxford, England)|May 12, 2022
Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study reportCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.Pageof 5